Incidence, risk factors and therapy response of acute graft-versus-host disease after myeloablative hematopoietic stem cell transplantation with posttransplant cyclophosphamide

Autor: Asensi Cantó, P., Gómez-Seguí, I., Montoro, J., Villalba Montaner, M., Chorão, P., Solves Alcaína, P., Santiago Balsera, M., Lloret Madrid, P., Solís Ruiz, J., Sopeña Pell-Ilderton, C., Martínez Campuzano, D., Granados Serrano, P., Eiris del Río, J., Louro, A., Rebollar, P., Perla, A., Benavente, R., De la Rubia Comos, J., Sanz, M. A., Balaguer, A., Sanz, J.

Publikováno v: Bone Marrow Transplantation; November 2024, Vol. 59 Issue: 11 p1577-1584, 8p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Acute hemolytic reaction by anti-Wra: Case report and review of the hemovigilance database of a tertiary care hospital

Autor: Solves P, Tur S, Gómez-Seguí I, Viel M, Eiris J, Planells Y, Rodríguez R, Peñalver I, Castro E, de la Rubia J

Publikováno v: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Wra is the most common LIA in white population. The incidence of Wra antigen in Spanish population has been estimated to be 1 in 785 in blood donors, while anti-Wra was found in 2.7 % and 3.6 % of healthy donors and transfused patients respectively.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::7133c0b0572a95dc16ddb769e077a2fe
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15437

Genome-wide association study identifies susceptibility loci for acute myeloid leukemia

Autor: Lin WY, Fordham SE, Hungate E, Sunter NJ, Elstob C, Xu Y, Park C, Quante A, Strauch K, Gieger C, Skol A, Rahman T, Sucheston-Campbell L, Wang J, Hahn T, Clay-Gilmour AI, Jones GL, Marr HJ, Jackson GH, Menne T, Collin M, Ivey A, Hills RK, Burnett AK, Russell NH, Fitzgibbon J, Larson RA, Le Beau MM, Stock W, Heidenreich O, Alharbi A, Allsup DJ, Houlston RS, Norden J, Dickinson AM, Douglas E, Lendrem C, Daly AK, Palm L, Piechocki K, Jeffries S, Bornhäuser M, Röllig C, Altmann H, Ruhnke L, Kunadt D, Wagenführ L, Cordell HJ, Darlay R, Andersen MK, Fontana MC, Martinelli G, Marconi G, Sanz MA, Cervera J, Gómez-Seguí I, Cluzeau T, Moreilhon C, Raynaud S, Sill H, Voso MT, Lo-Coco F, Dombret H, Cheok M, Preudhomme C, Gale RE, Linch D, Gaal-Wesinger J, Masszi A, Nowak D, Hofmann WK, Gilkes A, Porkka K, Milosevic Feenstra JD, Kralovics R, Grimwade D, Meggendorfer M, Haferlach T, Krizsán S, Bödör C, Stölzel F, Onel K, Allan JM

Publikováno v: NATURE COMMUNICATIONS
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Acute myeloid leukemia (AML) is a hematological malignancy with an undefined heritable risk. Here we perform a meta-analysis of three genome-wide association studies, with replication in a fourth study, incorporating a total of 4018 AML cases and 104

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::a87982b6c8c04fd9ebef07800bdebdba
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15221

A critical evaluation of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura

Autor: Gómez Seguí, I, FERNÁNDEZ, M, de la Rubia, J

Publikováno v: Expert Review Of Hematology
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Expert review of hematology
r-FISABIO. Repositorio Institucional de Producción Científica
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)

Introduction: Acquired thrombotic thrombocytopenic purpura (aTTP) is a thrombotic microangiopathy caused by inhibitory autoantibodies against ADAMTS13 protein. Until recently, the combination of plasma exchange (PEX) and immunosuppression has been th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::52d710737f4b01a5a8caf0cc6452e2a0
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13032